$RFL News Article - Rafael Pharmaceuticals Enters into Out-Licensing Agreement with Ono Pharmaceutical to Accelerate Clinical Development and Commercialization of Cancer Drug Candidate CPI-613 (devimistat) in Japan and Other Asian Countries
https://marketwirenews.com/news-releases/rafa...09954.html